Paper
Glimepiride enhances intrinsic peroxisome proliferator-activated receptor-gamma activity in 3T3-L1 adipocytes.
Published Mar 11, 2005 · K. Inukai, Masaki Watanabe, Y. Nakashima
Biochemical and biophysical research communications
44
Citations
0
Influential Citations
Abstract
Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
In Vitro Study
Study Snapshot
Glimepiride improves insulin resistance by inducing PPAR gamma activity in adipocytes, promoting adipocyte differentiation and promoting insulin secretion.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.
Full text analysis coming soon...
References
—
···
—
···
—
···
—
···
—
···
—
···
—
···
—
···
Citations
—
···
—
···
—
···
—
···
—
···
—
···
—
···
—
···